ecancermedicalscience editor's choice for September 2015

Surgery in synchronous oligometastatic disease

Are we providing adequate surgical care?

European Pharma companies to disclose health professional payments

First ‘targeted’ treatment for small cell lung cancer shows promise

Results of a placebo­ controlled study of tasquinimod in men with metastatic castrate resistant prostate cancer

Brain metastases genomic analysis could reveal new targets for treatment

Hodgkin lymphoma incidence in young affected by social deprivation, gender

HPV vaccines for cancer prevention

Is it possible to develop cancer drugs at a lower cost?

Examining NSCLC responses to durvalumab monotherapy

A cancer diagnosis while pregnant should not lead to treatment delay or pregnancy termination